[The ototoxicity of cisplatin in the chemotherapy of tumors of the head-neck area. Our experience].
The literature reports conflicting results on ototoxicity, one of the best known adverse effects of cis-platinum. An audiometric study was therefore performed in patients treated with this drug for tumours of the head and neck. The possible hearing loss does not rule out the use of cis-platinum in our experience.